Pfizer’s experimental drug improves survival rates in hard-to-treat bladder cancer
Bharti Jayshankar January 11, 2024: In a breakthrough for bladder cancer treatment, Pfizer’s experimental anti-PD-1 therapy demonstrated superior efficacy compared to the current.